PREDNISOLONE, Placebo for Depemokimab Injection, Placebo for Prednisolone
217013
Phase 3 small_molecule active
Quick answer
PREDNISOLONE, Placebo for Depemokimab Injection, Placebo for Prednisolone for Hypereosinophilic Syndrome (HES) is a Phase 3 program (small_molecule) at GlaxoSmithKline Biologicals S.A. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- GlaxoSmithKline Biologicals S.A.
- Indication
- Hypereosinophilic Syndrome (HES)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active